Search results
Results from the WOW.Com Content Network
Patricia Era Bath (November 4, 1942 – May 30, 2019) was an American ophthalmologist and humanitarian. She became the first female member of the Jules Stein Eye Institute , the first woman to lead a post-graduate training program in ophthalmology , and the first woman elected to the honorary staff of the UCLA Medical Center .
Patent applicants who are unhappy with the final decision of the USPTO's Patent Trial and Appeal Board have two options to appeal: they can appeal to the Federal Circuit (which conducts a limited review of the Patent Trial and Appeal Board's decision) or sue the USPTO Director in the Eastern District of Virginia (which can consider new evidence ...
Bath, Patricia: 1942–2019 Ophthalmologist: First African-American female physician to receive a patent for a medical invention; inventions relate to cataract surgery and include the Laserphaco Probe, which revolutionized the industry in the 1980s, and an ultrasound technique for treatment [19] [20] [21] Beard, Andrew: 1849–1921
The Court found contributory infringement for the sale of the defendant's ink with patent owners machine. Westinghouse Electric and Manufacturing Company v. Wagner Electric and Manufacturing Company. - Supreme Court, 1912. Bauer & Cie. v. O'Donnell - Supreme Court, 1913. Patent licensing terms do not include dictating the price of the product ...
Women inventors have been historically rare in some geographic regions. For example, in the UK, only 33 of 4090 patents (less than 1%) issued between 1617 and 1816 named a female inventor. [1] In the US, in 1954, only 1.5% of patents named a woman, compared with 10.9% in 2002. [1]
Here's what AOL readers were buying during the Cyber Monday sale at Walmart
The Lens, formerly called Patent Lens, is a free searcheable online patent and scholarly literature database, provided by Cambia, an Australia-based non-profit organization. The Lens is an agglomeration database, that takes bibliometric data from other databases (such as Crossref , PubMed , Microsoft Academic and Open Alex ) and combines them ...
An inter partes review is used to challenge the patentability of one or more claims in a U.S. patent only on a ground that could be raised under 35 U.S.C. §§ 102 or 103 (non-obviousness), and only on the basis of prior art consisting of patents or printed publications. [3]